Christian Meier
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Use of soluble guanylyl cyclase stimulators in heart failure therapy-a mode of action perspective.
Journal: ESC heart failure
Published: October 10, 2025
Predicting Response to Switching From Phosphodiesterase Type 5 Inhibitor to Riociguat in Patients With Pulmonary Arterial Hypertension: Biomarker and Responder Analysis of the RESPITE and REPLACE Studies.
Journal: Pulmonary circulation
Published: January 20, 2025
Application of REVEAL Lite 2 and COMPERA 2.0 risk scores to patients with pulmonary arterial hypertension switching to riociguat in the REPLACE study.
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Published: October 27, 2023
Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Journal: European respiratory review : an official journal of the European Respiratory Society
Published: April 08, 2022
Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension.
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Published: September 10, 2021
Soluble GC stimulators and activators: Past, present and future.
Journal: British journal of pharmacology
Published: August 23, 2021
Application of the REVEAL risk score calculator 2.0 in the CHEST study.
Journal: Respiratory medicine
Published: August 09, 2021
Muscarinic Receptor Activation Reduces Force and Arrhythmias in Human Atria Independent of IK,ACh.
Journal: Journal of cardiovascular pharmacology
Published: June 02, 2021
Effect of riociguat on right ventricular function in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Published: January 06, 2021
Change in REVEAL Lite 2 risk score predicts outcomes in patients with pulmonary arterial hypertension in the PATENT study.
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Published: December 20, 2020
Application of the REVEAL risk score calculator 2.0 in the PATENT study.
Journal: International journal of cardiology
Published: December 18, 2020
Assessment of the REPLACE study composite endpoint in riociguat-treated patients in the PATENT study.
Journal: Pulmonary circulation
Published: July 31, 2020
Last Updated: 09/26/2026